6th Annual Immuno-Oncology BD&L and Investment Forum is organized by Fred Hutchinson Cancer Research Center and will be held on May 29, 2020 at Chicago, Illinois, United States of America. Target Audience: This Conference is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. Additional details will be posted as soon as information is available.

MET Inhibition in Advanced NSCLC: Molecular Testing for METex14 and Emerging Options is organized by Clinical Care Options (CCO), LLC and will be held on May 30, 2020 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for global medical oncologists, pulmonologists and other healthcare providers who care for patients with NSCLC. Accreditation: This Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits™ Goal Statement The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize the care of their patients with MET-altered NSCLC. Learning Objectives: Upon completion of this activity, participants should be able to: • Describe the rationale for METex14 as a targetable alteration in NSCLC • Evaluate the available testing platforms and use of tissue and plasma biopsies to assess METex14 in patients with NSCLC • Discuss the available clinical evidence for selective MET inhibitors in METex14-altered NSCLC, including an assessment of relative efficacy and central nervous system responses • Appropriately manage treatment-related adverse events associated with MET targeted agents used in patients with advanced-stage NSCLC Additional details will be posted as soon as information is available.

Chronic Lymphocytic Leukemia: New Horizons with BTK Inhibitors is organized by Clinical Care Options (CCO), LLC and will be held on May 30, 2020 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for hematologists, hematologist-oncologists, and other clinicians involved in the management of patients with CLL and other B-cell malignancies. Accreditation: CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Learning Objectives: Upon completion of this activity, participants should be able to: • Evaluate differences among agents targeting BTK in terms of molecular characteristics, selectivity, preclinical data, approved indications, dosing, safety profile, and efficacy • Delineate the variables to be considered in selecting treatment for CLL including tumor characteristics such as biomarkers and patient characteristics and preferences • Describe clinical trial results providing evidence for the important role of BTK inhibitor based combinations in first-line treatment of CLL including phase III and phase II trials • Select patients most likely to benefit from continuous first-line treatment options and those patients most likely to benefit from time-limited first line options • Plan optimal, individualized therapeutic strategies for patients CLL taking into consideration recent practice-changing clinical trial results • Recognize and manage adverse events and toxicities associated with BTK inhibitor therapy to support adherence, appropriate dosing, quality of life, and continuation of treatment • Assess ongoing clinical trials evaluating currently available and emerging BTK inhibitors (and BTK-based combinations) to aid clinical trial enrollment and predict new options in the clinic

Practical Insights on Evolving Biomarkers for Precision Therapy in Lung Cancer is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2020 at Sheraton Grand Chicago, Chicago, Illinois, United States of America. Target Audience: This program is intended for physicians, pathologists, and other healthcare providers who care for patients with lung cancer. Accreditation: CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Board of Internal Medicine Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. American Board of Pathology Continuing Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Lifelong Learning (Part II) and Self-Assessment Module (SAM) point in the American Board of Pathology’s Maintenance of Certification (MOC) Program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Continuing Certification (formerly Maintenance of Certification or MOC) credit. Goal Statement: The goal of this activity is to improve the knowledge, competence, and performance of learners to assess new and emerging biomarkers and planning individualized treatment for patient with lung cancer. Learning Objectives: Upon completion of this activity, participants should be able to: • Apply new and emerging predictive biomarkers to guide therapeutic decisions in patients with lung cancer • Summarize the available data and expert recommendations to determine which biomarkers should be tested in your patients with lung cancer • Evaluate the available next-generation sequencing and comprehensive genomic profiling diagnostic assays Identify patients eligible to enroll on important ongoing clinical trials based on molecular testing of their tumor Additional details will be posted as soon as information is available.

HIV/HCV Mini-Residency is organized by The University of Chicago - Center for Continuing Medical Education and will be held from Jun 03 - 05, 2020 at University of Chicago Medicine, Chicago, Illinois, United States of America. Target Audience: This activity is designed for physicians and other healthcare professionals including prescribers such as nurse practitioners and physician assistants, pharmacists, and nurses committed to the treatment and care of patients living with HIV, HCV, and other related conditions. Credits: • 14.75 AMA PRA Category 1 Credit™ • 14.75 Participation Course Description: The mini-residency is a two-and-a-half-day intensive HIV educational experience. Lectures on a variety of HIV-related topics are interspersed with case studies and clinical encounters with patients where the lecture information can be immediately applied to real-time patient situations. Participants will also have opportunity to discuss questions and cases with Dr. Sherer and his colleagues. Learning Objectives: At the conclusion of this activity, participants should be able to: • Describe current trends in HIV and viral hepatitis epidemiology in the US; • Discuss the fundamentals and new trends in HIV and hepatitis prevention, HIV and HCV testing, and counseling, including the use of PrEP and the use of ART for prevention; • Relate the natural history of HIV infection and disease pathogenesis; • List the classes and targets of anti-retroviral drugs as well as their side effects and indications for use; • Identify new directly acting agents for the treatment of hepatitis B and C, and key considerations in the management of HIV/hepatitis co-infected patients; • Cite factors leading to drug resistance and three ways to reduce the risk of drug resistance.

This conference has been CANCELLED. 2020 American Medical Association (AMA) Annual Section Meetings is organized by American Medical Association (AMA) and will be held from Jun 04 - 08, 2020 at Hyatt Regency Chicago, Chicago, Illinois, United States of America. Additional details will be posted as soon as information is available.

Rush University Teaching Excellence Bootcamp is hosted by Center for Innovative and Lifelong Learning (CILL) and will be held from Jun 04 - 06, 2020 at Rush University - Rush Professional Building, Chicago, Illinois, United States of America. Description: Rush University's Faculty Affairs Office is equally committed to the student learning experience and the professional development of our faculty. Over the last 5 years, we have partnered with exceptional faculty educators from around the Chicago-land area to provide faculty with intensive training to elevate and enhance their teaching skills. With years of course development and validation, this bootcamp offers evidence-based and highly interactive sessions with large- and small-group break outs. This three-day CE-eligible bootcamp focuses on key topics necessary for cutting edge interprofessional education: the evolution of learning theories, creating effective objectives and assessments, course organization and delivering constructive feedback to learners, among others. The intended audience is faculty in Health Care Academic Institutions who are involved in various teaching modalities and settings. Participants will walk away with concrete tools and contemporary best practices that can be immediately applied in their daily educational endeavors. Accreditation: In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team. Rush University Medical Center designates this live activity for a maximum of (20.75) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. ANCC Credit Designation – Nurses The maximum number of hours awarded for this CE activity is (20.75) contact hours. Rush University is an approved provider for physical therapy (216.000272), occupational therapy, respiratory therapy, social work (159.001203), nutrition, speech-audiology, and psychology by the Illinois Department of Professional Regulation. Rush University designates this live activity for (20.75) Continuing Education credit(s). This activity is being presented without bias and without commercial support. Session topics include: The Evolution of Learning Theories and Adult Learning Theory (Active Learning Model) Exploring the Brain, Memory, and How People Learn Course Organization Writing Effective Learning Objectives Learner Assessment (Formative and Summative) Writing Exam Questions Rubrics Learner Management Active Learning: Small group, case-based Providing Constructive Feedback Registration includes 6 meals, a CE certificate, teaching reference book.

Dental Management of Sleep Apnea & Snoring is organized by Sleep Group Solutions (SGS) and will be held from Jun 05 - 06, 2020 at Chicago, Illinois, United States of America. This course has been approved for a maximum of 16 CEU.  Description: This is a MUST attend for any dental office that is looking to implement a Sleep Protocol, or learn how to increase existing Sleep revenues. Day 1: ● Sleep 101 – sleep stages, disorders and the need for sleep apnea treatment ● Sleep apnea symptoms/clinical issues ● Improving Case Acceptance - Treating snoring and sleep apnea in a dental office. ● Prepare overnight home sleep study for select course attendees ● Hands on with Pharyngometer / Rhinometer for airway testing ● Working with Sleep Physicians and Building relationships with local MD’s Day 2: ● Download previous night’s Home Sleep Tests study and review study data and sleep report with class ● Dental Sleep Medicine step-by-step protocol flow chart ● Oral Appliance Pro’s & Con’s: Dorsal, Herbst, EMA, TAP, Panthera, and SomnoMed ● Case presentations and How to Market a Sleep Practice ● Review of the latest codes, fees, procedures with medical billing and Medicare. Additional details will be posted as soon as information is available.

Sexual Dysfunction Training for Men and Women is organized by Empire Medical Training (EMT), Inc and will be held on Jun 05, 2020 at Loyola University Chicago, Chicago, Illinois, United States of America. Description: Sexual dysfunction is one of the largest and fastest growing segments within medicine. The statistics are staggering and yet both physician and patients are unaware of the breakthroughs in medicine that allow for effective treatment in both men and women. Erectile dysfunction affects almost all men at one time or another in their lives and effects more than 30 million American men. Women suffer from sexual dysfunction more than men due to differing perceptions of sexual intercourse; about 43% of women in America suffer from female sexual dysfunction. The annual revenue growth since 2007 is 7.8% and projected growth going forward is at 9.2% per year. The Sexual Dysfunction Course has been separated to include men and women as well as the diagnosis, treatments available and standard of care needed. In men, cases for erectile dysfunction will more than double over the next 25 years due to population trends. The worldwide incidence of erectile dysfunction estimated at over 152 million men, with a forecast of 322 million men by the year 2025. About 80% of erectile dysfunction goes unreported while the 52% of men who suffer from erectile dysfunction 17% have minimal ED, 25% have moderate ED, and 10% have complete ED – all of which have effective treatment options available to them. Additional details will be posted as soon as information is available.

Hormone Pellet Training and Therapies is organized by Empire Medical Training (EMT), Inc and will be held on Jun 05, 2020 at Loyola University Chicago, Chicago, Illinois, United States of America. Description: Empire Medical Training is proud to provide our newest and most advanced segment on Anti Aging Medicine involving Hormone Pellet Therapy. Pellet Therapy has become the most sought after mechanism for delivering the optimal levels and benefits achievable with Bio-Identical Hormone Therapies. Hormone Pellet Therapy has significantly changed the manner in which both men and women will age. Hormone Therapies and the ongoing advancements in Anti Aging Medicine continue to help improve the quality and the longevity of our lives. Pellet Implantation has consistently proven to be more effective than the oral, intramuscular, and topical modalities for hormone therapies as relates to a variety of conditions such as bone density, sexual dysfunction, psychiatric problems related to mood and cognition, renal and genito- urinary and vaginal complaints, female breast health, triglycerides and lipid panel, hormone ratios and metabolites. Empire Medical Training has created this course as an extension of the Anti Aging Module 1 & 2 program to allow for physicians to enjoy these in demand procedures related to hormone replacement. Additional details will be posted as soon as information is available.